The recently published Lancet Oncology paper by Gemma Gatta et al. provides the EUROCARE 5 results on childhood cancer survival in Europe between 2005 - 2007 as compared to previous years. The 5-year survival for all cancers is 79.1%, as compared to 76.1% before 2001. The two main messages from the paper are :
- No improvement in paediatric malignancies with the poorest prognosis (brain, neuroblastoma, sarcoma), while prognosis of AML remains poor;
- Significant disparity in survival across Europe with 10 to 20 % less in Eastern European countries.